Jane Street’s Kite Pharma, Inc. KITE Stock Holding History

Jane Street’s Portfolio KITE Stock Details KITE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q4	–	Sell	-36,200	Closed	-$6.51M	–	5572
2017 Q3	$6.51M	Sell	36,200 -34,200	-49%	-$4.77M	0.02%	710
2017 Q2	$7.3M	Buy	70,400 +48,600	+223%	+$3.97M	0.03%	594
2017 Q1	$1.71M	Buy	+21,800	New	+$1.35M	0.01%	1521
2016 Q4	–	Sell	-63,100	Closed	-$3.52M	–	4931
2016 Q3	$3.52M	Buy	63,100 +42,300	+203%	+$2.36M	0.02%	786
2016 Q2	$1.04M	Buy	20,800 +10,300	+98%	+$506K	0.01%	1936
2016 Q1	$482K	Buy	+10,500	New	+$509K	﹤0.01%	2643
2015 Q3	–	Sell	-9,300	Closed	-$567K	–	4472
2015 Q2	$567K	Buy	+9,300	New	+$531K	﹤0.01%	2156

Jane Street's KITE Position: Q4 2017 in Review

Jane Street sold out of Kite Pharma, Inc. (KITE) in Q4 2017, closing a stake of 84,746 shares — an estimated $15.2M sold.

Jane Street first reported a position in KITE in Q3 2014 and held it in 10 quarters. The position peaked at $15.2M in Q3 2017. 0 funds tracked by Wall St. Rank hold KITE as of Q4 2017.

Jane Street reported no remaining Kite Pharma, Inc. position as of Q4 2017 after selling out during the quarter.
Jane Street sold 84,746 Kite Pharma, Inc. shares in Q4 2017, an estimated $15.2M.
Jane Street first reported a position in Kite Pharma, Inc. in Q3 2014 and held it in 10 quarters.
Jane Street's Kite Pharma, Inc. position peaked at $15.2M in Q3 2017.
0 funds tracked by Wall St. Rank held Kite Pharma, Inc. as of Q4 2017.

Based on Jane Street's 13F filing for Q4 2017, filed 15 Feb 2018.